| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 19.601 | 120.889 | 114.905 | 5.758 | 0 |
| Total Income - EUR | - | - | - | - | - | 19.601 | 121.182 | 115.014 | 42.677 | 0 |
| Total Expenses - EUR | - | - | - | - | - | 17.069 | 116.627 | 127.878 | 79.619 | 10.220 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 2.533 | 4.555 | -12.864 | -36.942 | -10.220 |
| Net Profit/Loss - EUR | - | - | - | - | - | 2.337 | 3.343 | -14.014 | -37.653 | -10.220 |
| Employees | - | - | - | - | - | 1 | 2 | 3 | 1 | 0 |
Check the financial reports for the company - Andrexil Active S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 12.654 | 64.552 | 65.688 | 29.232 | 53.857 |
| Current Assets | - | - | - | - | - | 12.390 | 19.852 | 16.375 | 23.130 | 11.325 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 9.963 | 17.995 | 8.091 | 5.150 | 6.412 |
| Cash | - | - | - | - | - | 2.427 | 1.857 | 8.284 | 17.980 | 4.914 |
| Shareholders Funds | - | - | - | - | - | 2.419 | 5.709 | -8.288 | -45.915 | -39.527 |
| Social Capital | - | - | - | - | - | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | - | - | 22.626 | 78.695 | 90.351 | 98.277 | 104.710 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4520 - 4520" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Andrexil Active S.r.l.